Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer
Zehua Wu(Shanghai Jiao Tong University), Yanhong Deng(Sun Yat-sen University), Xiaoxing Qi(Henan Medical University), Runkai Cai(Sun Yat-sen University), Jianwei Zhang(Capital Medical University), Weiwei Li, Chao Wang(Sun Yat-sen University), Yuting Zhang(Shenzhen University), Hong Huo(China Medical University), Huaiming Wang(Sun Yat-sen University), Dian Liu(Central South University), Yuanzhe Zhang(Sun Yat-sen University), Huabin Hu(Sun Yat-sen University), Yi Cheng(Nanjing Medical University), Yue Cai(Sun Yat-sen University)
Cited by 6
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402